LGND Financing Cash Flow
Ligand Pharmaceuticals Inc · Financing Cash Flow

LGND Financing Cash Flow
Latest reported$950.28Mperiod ending
LGND Cash from Financing ($19.20M → $950.28M)
Annual financing cash flow
High-resolution chart · PNG
LGND financing cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 428,223,000 | |
| 97,141,000 | |
| -59,947,000 | |
| -275,990,000 | |
| -137,761,000 | |
| -310,545,000 | |
| -485,172,000 | |
| 328,585,000 | |
| -7,523,000 | |
| 1,515,000 | |
| 8,360,000 | |
| 130,025,000 | |
| -16,458,000 | |
| 3,916,000 | |
| 29,999,000 | |
| -159,000 | |
| -3,688,000 | |
| -3,010,000 | |
| -327,699,000 | |
| 33,301,000 | |
| -201,000 | |
| 7,915,000 | |
| 40,952,000 | |
| 152,039,000 | |
| 35,595,000 | |
| 12,025,000 | |
| 82,500,000 | |
| 65,800,000 | |
| 36,500,000 | |
| 44,700,000 | |
| 17,600,000 | |
| 19,200,000 |